# Use of Cidofovir for Recurrent Respiratory Papillomatosis

> **NCT00205374** · PHASE4 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 19 (actual)

## Conditions studied

- Recurrent Respiratory Papillomatosis

## Interventions

- **DRUG:** Cidofovir
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00205374
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-11
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2019-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00205374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00205374, "Use of Cidofovir for Recurrent Respiratory Papillomatosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00205374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*